Distinct sets of genetic alterations in melanoma

New England Journal of Medicine

Volumn 353, Issue 20, 2005, Pages 2135-2147

  Curtin, John A ^a   Fridlyand, Jane ^a,b   Kageshita, Toshiro ^d   Patel, Hetal N ^a   Busam, Klaus J ^e   Kutzner, Heinz ^f   Cho, Kwang Hyun ^g   Aiba, Setsuya ^h   Bröcker, Eva Bettina ⁱ   LeBoit, Philip E ^c   Pinkel, Dan ^a   Bastian, Boris C ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KUMAMOTO UNIVERSITY   (Japan)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f Dermatopathologische Gemeinschaftspraxis   (Germany)

^g Seoul National University   (South Korea)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; DNA; GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GENOME; HUMAN; HYPOTHESIS; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUTATION RATE; ONCOGENE N RAS; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN DEFECT; SUN EXPOSURE; ULTRAVIOLET RADIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; DNA, NEOPLASM; ENVIRONMENTAL EXPOSURE; FEMALE; GENES, RAS; GENOME, HUMAN; HUMANS; MALE; MELANOMA; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NUCLEIC ACID HYBRIDIZATION; PROTO-ONCOGENE PROTEINS B-RAF; PTEN PHOSPHOHYDROLASE; RISK FACTORS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 27844567142     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa050092     Document Type: Article

References (38)

1. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000;25:459-63.
2. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001;12:69-82.
3. MacKie RM, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant-melanoma in Scotland. Br J Cancer 1982;46:955-60.
4. Beral V, Robinson N. The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Br J Cancer 1981;44:886-91.
5. Vagero D, Ringback G, Kiviranta H. Melanoma and other tumors of the skin among office, other indoor and outdoor workers in Sweden 1961-1979. Br J Cancer 1986;53:507-12.
6. Albino AP, Nanus DM, Mentle IR, et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 1989;4:1363-74.
7. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
8. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-27.
9. McGovern VJ, Mihm MC Jr, Bailly C, et al. Classification of malignant melanoma and its histologic reporting. Cancer 1973;32:1446-57.
10. Ackerman AB. Malignant melanoma: a unifying concept. Hum Pathol 1980;11:591-5.
11. Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 1996;78:427-32. [Erratum, Cancer 1997;79:423.]
12. Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992;8:400-14.
13. Whiteman DC, Parsons PG, Green AC. p53 Expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 1998;77:843-8.
14. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003;95:806-12.
15. Rivers JK. Is there more than one road to melanoma? Lancet 2004;363:728-30.
16. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003;95:1878-90.
17. Bastian BC, Kashani-Sabet M, Hamm H, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 2000;60:1968-73.
18. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003;163:1765-70.
19. van Dijk M, Sprenger S, Rombout P, et al. Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization. Genes Chromosomes Cancer 2003;36:151-8.
20. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-11.
21. Snijders AM, Nowak N, Segraves R, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001;29:263-4.
22. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998;58:2170-5.
23. Snijders AM, Fridlyand J, Mans DA, et al. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene 2003;22:4370-9.
24. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000;157:967-72.
25. Sauter ER, Yeo UC, von Stemm A, et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 2002;62:3200-6.
26. Fridlyand J, Snijders AM, Pinkel D, Albertson DG, Jain AN. Hidden Markov models approach to the analysis of array CGH data. J Multivariate Anal 2004;90:132-53.
27. Fridlyand J, Dimitrov P. Package: aCGH. (Accessed October 21, 2005, at http://www.bioconductor.org/repository/release1.5/package/html/aCGH.html.)
28. Cleveland WS. Lowess: a program for smoothing scatterplots by robust locally weighted regression. Am Stat 1981;35:54.
29. Westfall PH, Young SS. Resampling-based multiple testing: examples and methods for P-value adjustment. New York: John Wiley, 1993.
30. Dudoit S, Fridlyand J, Speed TP. Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc 2002;97:77-87.
31. Ikaka R, Gentleman R. R, a language for data analysis and graphics. J Comput Gr Stat 1996;5:229-314.
32. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
33. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
34. Tsao H, Zhang X, Fowlkes K, Haluska FG. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res 2000;60:1800-4.
35. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20.
36. Noonan FP, Recio JA, Takayama H, et al. Neonatal sunburn and melanoma in mice. Nature 2001;413:271-2.
37. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994;30:40-8.
38. Lyons JF, Wilhelm S, Hibner B, Bollag G. Discovery of a novel Raf kinase inhibitor. Endocr Relat Cancer 2001;8:219-25.